### Comment:
a drug doesn't have to have 'no' side effects and nobody expects it to; it just needs to have a positive benefit:risk ratio. If you are a doctor you would know that statins are PLAGUED by side effects such as myalgia and that the prevalence of statin-intolerant people seem to be exploding. ESPR's BA so far looks way, way safer than statins. Even if this had to be used in statin-intolerent ppl only, the market is huge

### REPLY:
Agree that it doesn't have to have 'no' side effects to be successful - was just commenting on your original statement of the drug having no side effects. 10% of the market is indeed large, if we assume that it can capture that share from other available statin competitors.

### END.